Evidence map›Paper›PMID 39944871›Full record

ArticleTranslational pediatrics2025

Age- and sex-specific reference intervals for sex hormones in children in Wuhan: a cross-sectional study of 2,477 healthy children and adolescents.

Lun Zhao, Wenbin Tuo, Jun Wang, Chunhui Yuan, Wei Luo, Mo Wu, Xiaoqian Chen, Si Xie, Liping Li, Yu Shang and 5 more

Abstract read
In one paragraph

Article in Translational pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lun Zhao *Department of Laboratory Medicine, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Wenbin Tuo *Department of Laboratory Medicine, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Jun Wang *Department of Laboratory Medicine, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Chunhui YuanDepartment of Laboratory Medicine, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Wei LuoIVD Clinical Research & Medical Affairs, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China.
Mo WuDepartment of Laboratory Medicine, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Xiaoqian ChenDepartment of Endocrinology, Genetics & Metabolism, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Si XieDepartment of Laboratory Medicine, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Liping LiIVD Clinical Research & Medical Affairs, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China.
Yu ShangDepartment of Laboratory Medicine, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Chengdong QiuIVD Clinical Research & Medical Affairs, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China.
Yun XiangDepartment of Laboratory Medicine, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Hong SunDepartment of Laboratory Medicine, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Cong YaoHealth Care Department, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Qinzhen CaiDepartment of Laboratory Medicine, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The standards for diagnosing, monitoring, and treating endocrine diseases in pediatric patients often rely on laboratory assessments of children's growth and differentiation markers, among which sex hormones are pivotal. Nonetheless, due to the rapid development during childhood and adolescence and the substantial physiological differences between children and adults, sex hormone levels undergo significant fluctuations. Unfortunately, few laboratories in China currently provide reliable reference intervals (RIs) for children's sex hormones. Hence, it is imperative to establish age-, sex-, and assay-RIs for sex hormones. In this study, age- and sex-specific pediatric RIs for estradiol (E2), follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), progesterone (PROG), and testosterone (TESTO) were established using a Mindray automatic chemiluminescence immunoassay analyzer (CL-6000i). Methods: In this cross-sectional study, a total of 2,477 healthy children and adolescents from birth to 19 years were recruited in Wuhan Children's Hospital from September 2022 to August 2023, and serum samples were collected. Serum samples were analyzed on a Mindray analyzer (CL-6000i) for detection of sex hormones, including E2, FSH, LH, PRL, PROG, and TESTO. After sample analysis, age- and sex-specific differences were assessed. RIs were established according to guideline C28-A3 of the Clinical Laboratory Standards Institute (CLSI). Results: We observed a complex pattern of changes in the concentrations of various hormones from the neonatal period through adolescence. Given the sex- and age-dependent variations in all sex hormones, we identified the need for establishing specific RIs for several subgroups to capture the fluctuations in hormone levels across this developmental spectrum. Notably, during the first month of life, significant variations were observed in all six hormones levels, necessitating further subdivisions within the first year. Additionally, age groups demonstrating nonsignificant differences in hormone concentrations were merged, resulting in different age subgroups for each of the six sex hormones. Conclusions: We established specific pediatric RIs for sex hormones in both male and female children and adolescents, and also examined the age- and sex-specific differences, aligning them with medical literature, thereby facilitating the interpretation of patient results.

Indexed as

Mindray analyzerpediatricreference intervals (RI)Sex hormones

Identifiers

PMID39944871
PMCPMC11811589

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.